Tumor Ablation Market Forecast Global Demand, Trends, and Regional Analysis to 2032

Tumor Ablation Market Overview:

The Tumor Ablation Market is witnessing remarkable growth as minimally invasive procedures gain traction as effective cancer treatment options. Ablation techniques, including liver ablation and ablation for lung cancer, are playing a crucial role in this market's expansion.

Minimally Invasive Tumor Ablation Techniques

Tumor ablation involves destroying cancerous cells using various energy sources while minimizing damage to surrounding healthy tissues. Liver ablation and ablation for lung cancer are two prominent applications of this technique, offering patients less invasive alternatives to surgery and chemotherapy.

Key Players

Tumor ablation players include

Covidien PL,

Misonix Inc.,

Galil Medical, Inc,

Biotronik,

Boston Scientific Corporation,

Neuwave Medical, Inc.,

Healthtronics Inc.,

AngioDynamics Inc.,

EDAP TMS,

Medtronic Plc., and

SonaCare Medical.

Liver Ablation: Advancing Treatment for Hepatic Tumors

Liver ablation is increasingly recognized as an effective treatment for hepatic tumors, including hepatocellular carcinoma (HCC) and metastatic liver tumors. Techniques such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation are commonly used for liver cancer treatment.

Radiofrequency Ablation (RFA): RFA uses high-frequency electrical currents to generate heat, effectively destroying cancer cells. It is a preferred option for small liver tumors and can be performed using minimally invasive techniques.

Microwave Ablation (MWA): MWA utilizes microwave energy to heat and destroy tumor cells. This technique offers faster and larger ablation zones compared to RFA, making it suitable for larger liver tumors.

Cryoablation: Cryoablation involves freezing cancerous tissues, leading to their destruction. It is particularly effective for tumors located near blood vessels or bile ducts.

Liver ablation procedures are often guided by imaging techniques such as ultrasound, CT scans, or MRI, ensuring precise targeting of tumors while sparing healthy liver tissue.

Ablation for Lung Cancer: Pioneering Minimally Invasive Solutions

Ablation techniques are also proving to be effective in treating lung cancer, offering hope to patients who are not suitable candidates for surgery or have early-stage lung cancer.

Radiofrequency Ablation (RFA): RFA is used to treat small lung tumors by delivering heat directly into the tumor tissue, destroying cancer cells while preserving healthy lung tissue.

Microwave Ablation (MWA): MWA is gaining popularity for treating lung tumors, providing faster and more uniform heating than RFA.

Cryoablation: Cryoablation for lung cancer involves freezing tumor tissues, effectively killing cancer cells while minimizing damage to surrounding lung tissue.

These ablation techniques are performed under imaging guidance, such as CT scans or fluoroscopy, to ensure accurate tumor targeting and treatment delivery.

Market Trends and Growth Drivers

The Tumor Ablation Market is driven by several factors, including:

Rising Cancer Incidence: The increasing prevalence of liver and lung cancers is driving the demand for tumor ablation procedures.

Technological Advancements: Continuous advancements in ablation technologies, including improved energy sources and imaging techniques, are enhancing treatment outcomes.

Growing Preference for Minimally Invasive Procedures: Patients prefer minimally invasive treatments due to faster recovery times, reduced risk of complications, and improved quality of life.

Expanding Applications: Ablation techniques are being explored for the treatment of various cancers beyond liver and lung, further expanding the market scope.

Future Outlook and Challenges

The future of the Tumor Ablation Market looks promising, with ongoing research and development aimed at improving treatment efficacy and patient outcomes. However, challenges such as limited access to advanced technologies in certain regions and the need for more robust clinical evidence for ablation techniques remain.

Related Report:

Electron Microscope Market

Traumatic Brain Injuries Treatment Market

Renal Denervation Market

Tumor Ablation Market

Substance Abuse Treatment Market

Tumor Ablation Market Poised for Sustainable Growth During Forecast Period

Tumor Ablation Market Overview:

The Tumor Ablation Market is witnessing remarkable growth as minimally invasive procedures gain traction as effective cancer treatment options. Ablation techniques, including liver ablation and ablation for lung cancer, are playing a crucial role in this market's expansion.

Minimally Invasive Tumor Ablation Techniques

Tumor ablation involves destroying cancerous cells using various energy sources while minimizing damage to surrounding healthy tissues. Liver ablation and ablation for lung cancer are two prominent applications of this technique, offering patients less invasive alternatives to surgery and chemotherapy.

Key Players

Tumor ablation players include

Covidien PL,

Misonix Inc.,

Galil Medical, Inc,

Biotronik,

Boston Scientific Corporation,

Neuwave Medical, Inc.,

Healthtronics Inc.,

AngioDynamics Inc.,

EDAP TMS,

Medtronic Plc., and

SonaCare Medical.

Liver Ablation: Advancing Treatment for Hepatic Tumors

Liver ablation is increasingly recognized as an effective treatment for hepatic tumors, including hepatocellular carcinoma (HCC) and metastatic liver tumors. Techniques such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation are commonly used for liver cancer treatment.

Radiofrequency Ablation (RFA): RFA uses high-frequency electrical currents to generate heat, effectively destroying cancer cells. It is a preferred option for small liver tumors and can be performed using minimally invasive techniques.

Microwave Ablation (MWA): MWA utilizes microwave energy to heat and destroy tumor cells. This technique offers faster and larger ablation zones compared to RFA, making it suitable for larger liver tumors.

Cryoablation: Cryoablation involves freezing cancerous tissues, leading to their destruction. It is particularly effective for tumors located near blood vessels or bile ducts.

Liver ablation procedures are often guided by imaging techniques such as ultrasound, CT scans, or MRI, ensuring precise targeting of tumors while sparing healthy liver tissue.

Ablation for Lung Cancer: Pioneering Minimally Invasive Solutions

Ablation techniques are also proving to be effective in treating lung cancer, offering hope to patients who are not suitable candidates for surgery or have early-stage lung cancer.

Radiofrequency Ablation (RFA): RFA is used to treat small lung tumors by delivering heat directly into the tumor tissue, destroying cancer cells while preserving healthy lung tissue.

Microwave Ablation (MWA): MWA is gaining popularity for treating lung tumors, providing faster and more uniform heating than RFA.

Cryoablation: Cryoablation for lung cancer involves freezing tumor tissues, effectively killing cancer cells while minimizing damage to surrounding lung tissue.

These ablation techniques are performed under imaging guidance, such as CT scans or fluoroscopy, to ensure accurate tumor targeting and treatment delivery.

Market Trends and Growth Drivers

The Tumor Ablation Market is driven by several factors, including:

Rising Cancer Incidence: The increasing prevalence of liver and lung cancers is driving the demand for tumor ablation procedures.

Technological Advancements: Continuous advancements in ablation technologies, including improved energy sources and imaging techniques, are enhancing treatment outcomes.

Growing Preference for Minimally Invasive Procedures: Patients prefer minimally invasive treatments due to faster recovery times, reduced risk of complications, and improved quality of life.

Expanding Applications: Ablation techniques are being explored for the treatment of various cancers beyond liver and lung, further expanding the market scope.

Future Outlook and Challenges

The future of the Tumor Ablation Market looks promising, with ongoing research and development aimed at improving treatment efficacy and patient outcomes. However, challenges such as limited access to advanced technologies in certain regions and the need for more robust clinical evidence for ablation techniques remain.

Related Report:

Electron Microscope Market

Traumatic Brain Injuries Treatment Market

Renal Denervation Market

Tumor Ablation Market

Substance Abuse Treatment Market

 

Key Players and Competitive Landscape in the Tumor Ablation Industry

Tumor Ablation Market Overview:

The Tumor Ablation Market is witnessing remarkable growth as minimally invasive procedures gain traction as effective cancer treatment options. Ablation techniques, including liver ablation and ablation for lung cancer, are playing a crucial role in this market's expansion.

Minimally Invasive Tumor Ablation Techniques

Tumor ablation involves destroying cancerous cells using various energy sources while minimizing damage to surrounding healthy tissues. Liver ablation and ablation for lung cancer are two prominent applications of this technique, offering patients less invasive alternatives to surgery and chemotherapy.

Key Players

Tumor ablation players include

Covidien PL,

Misonix Inc.,

Galil Medical, Inc,

Biotronik,

Boston Scientific Corporation,

Neuwave Medical, Inc.,

Healthtronics Inc.,

AngioDynamics Inc.,

EDAP TMS,

Medtronic Plc., and

SonaCare Medical.

Liver Ablation: Advancing Treatment for Hepatic Tumors

Liver ablation is increasingly recognized as an effective treatment for hepatic tumors, including hepatocellular carcinoma (HCC) and metastatic liver tumors. Techniques such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation are commonly used for liver cancer treatment.

Radiofrequency Ablation (RFA): RFA uses high-frequency electrical currents to generate heat, effectively destroying cancer cells. It is a preferred option for small liver tumors and can be performed using minimally invasive techniques.

Microwave Ablation (MWA): MWA utilizes microwave energy to heat and destroy tumor cells. This technique offers faster and larger ablation zones compared to RFA, making it suitable for larger liver tumors.

Cryoablation: Cryoablation involves freezing cancerous tissues, leading to their destruction. It is particularly effective for tumors located near blood vessels or bile ducts.

Liver ablation procedures are often guided by imaging techniques such as ultrasound, CT scans, or MRI, ensuring precise targeting of tumors while sparing healthy liver tissue.

Ablation for Lung Cancer: Pioneering Minimally Invasive Solutions

Ablation techniques are also proving to be effective in treating lung cancer, offering hope to patients who are not suitable candidates for surgery or have early-stage lung cancer.

Radiofrequency Ablation (RFA): RFA is used to treat small lung tumors by delivering heat directly into the tumor tissue, destroying cancer cells while preserving healthy lung tissue.

Microwave Ablation (MWA): MWA is gaining popularity for treating lung tumors, providing faster and more uniform heating than RFA.

Cryoablation: Cryoablation for lung cancer involves freezing tumor tissues, effectively killing cancer cells while minimizing damage to surrounding lung tissue.

These ablation techniques are performed under imaging guidance, such as CT scans or fluoroscopy, to ensure accurate tumor targeting and treatment delivery.

Market Trends and Growth Drivers

The Tumor Ablation Market is driven by several factors, including:

Rising Cancer Incidence: The increasing prevalence of liver and lung cancers is driving the demand for tumor ablation procedures.

Technological Advancements: Continuous advancements in ablation technologies, including improved energy sources and imaging techniques, are enhancing treatment outcomes.

Growing Preference for Minimally Invasive Procedures: Patients prefer minimally invasive treatments due to faster recovery times, reduced risk of complications, and improved quality of life.

Expanding Applications: Ablation techniques are being explored for the treatment of various cancers beyond liver and lung, further expanding the market scope.

Future Outlook and Challenges

The future of the Tumor Ablation Market looks promising, with ongoing research and development aimed at improving treatment efficacy and patient outcomes. However, challenges such as limited access to advanced technologies in certain regions and the need for more robust clinical evidence for ablation techniques remain.

Related Report:

Menstrual Cup market

Emergency Medical Services market

CBD Oil market

Medical Writing market

Tumor Ablation Market 2023 Global Outlook, Capacity and Capital Expenditure Forecasts

Market Analysis

The global tumor ablation market size is projected to reach at a stellar 11.8% CAGR during the forecast period (2023-2032).

The Tumor Ablation Market refers to the segment of the medical device industry dedicated to developing and providing technologies and procedures for the ablation or destruction of tumors. Tumor ablation techniques are minimally invasive procedures that use various energy sources, such as radiofrequency, microwave, cryoablation, high-intensity focused ultrasound (HIFU), and laser, to target and eliminate cancerous tissue.

This market has experienced significant growth in recent years due to several factors. One of the primary drivers is the increasing incidence of cancer worldwide, coupled with a growing demand for less invasive treatment options. Tumor ablation procedures offer a less traumatic alternative to traditional surgery, resulting in shorter hospital stays, faster recovery times, and reduced post-operative complications for patients.

The tumor ablation market is witnessing significant growth, driven by advancements in minimally invasive procedures such as radiofrequency ablation (RFA) and increasing adoption of liver ablation procedures. Radiofrequency ablation, a type of tumor ablation technique, utilizes heat generated by high-frequency alternating current to destroy cancerous cells. This innovative approach offers several advantages, including minimal invasiveness, reduced recovery time, and lower risk of complications compared to traditional surgical interventions. As a result, the demand for radiofrequency ablation procedures is on the rise, particularly for treating liver tumors and other solid tumors.

Market Segmentation

Market Research Future report offers a comprehensive segmental analysis of the tumor ablation market on the basis of technology, treatment, application and end-user.

Based on technology, it is segmented into cryoablation, irreversible electroporation, microwave, radiofrequency and others. Of these, radiofrequency will dominate the tumor ablation market during the forecast period. Prominent use of this technology to remove solid tumor and its specificity has resulted to its growth. Also, this method’s efficiency is expected to spur the segment growth. This will be followed by microwave ablation technology that is projected to have a remunerative growth due to the advantages provided by this technology namely optimal heating of cystic mass, reduced procedural pain, lesser time, constancy in high temperature and bigger tumor ablation volume.

Based on treatment, the tumor ablation market is segmented into laparoscopic, percutaneous and surgical. Of these, surgical will dominate the market during the forecast period owing to rising prevalence of breast and liver cancer that needs open surgical techniques. This will be followed by the percutaneous ablation that is projected to grow at the fastest pace.

Based on application, it is segmented into prostate cancer, bone cancer, breast cancer, lung cancer, liver cancer and others. Of these, liver cancer will have the largest share in the market owing to rising cases of both bile duct as well as primary liver cancers. Of these, lung cancer will lead the market during the forecast period owing to rising cases of the disease.

Based on end-user, the tumor ablation market is segmented into research institute, surgical and ablation centers and hospitals. Of these, hospitals will dominate the market due to increasing practices to visit the hospital for well-being along with the availability of various facilities in hospitals.

Key Players

Tumor ablation players include

Covidien PL,

Misonix Inc.,

Galil Medical, Inc,

Biotronik,

Boston Scientific Corporation,

Neuwave Medical, Inc.,

Healthtronics Inc.,

AngioDynamics Inc.,

EDAP TMS,

Medtronic Plc., and

SonaCare Medical.

Regional Analysis

By region, the tumor ablation market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain head and shoulders over other regions in the market. The growth can be attributed to factors such as increasing incidences of cancer amid rising elderly population, use of advanced healthcare facilities, favorable reimbursement policies, and increasing awareness regarding cancer detection as well as treatment. The tumor ablation market in Europe will grab the second position owing to rising prevalence of cancer coupled with increasing healthcare expenditure. The tumor ablation market in the APAC region will grow at the fastest pace due to high demand for advanced healthcare technologies, constantly growing investment in healthcare and rising geriatric population. On the other hand, the tumor ablation market in the Middle East and Africa will have a minimal share owing to poor medical facilities, dearth of technical knowledge and underdeveloped healthcare sector.

Related Reports-

RSV Diagnostics

Liver Biopsy

Biologic Therapy

US 3d medical printing

Epilepsy Diagnosis and Treatment

For more information, Please Visit us @ Market Research Future

Tumor Ablation Market Size, Share Business Outlook, Growth Opportunities, Trends and Forecasts

Market Analysis

The global tumor ablation market size is projected to reach at a stellar 11.8% CAGR during the forecast period (2023-2032).

The Tumor Ablation Market refers to the segment of the medical device industry dedicated to developing and providing technologies and procedures for the ablation or destruction of tumors. Tumor ablation techniques are minimally invasive procedures that use various energy sources, such as radiofrequency, microwave, cryoablation, high-intensity focused ultrasound (HIFU), and laser, to target and eliminate cancerous tissue.

This market has experienced significant growth in recent years due to several factors. One of the primary drivers is the increasing incidence of cancer worldwide, coupled with a growing demand for less invasive treatment options. Tumor ablation procedures offer a less traumatic alternative to traditional surgery, resulting in shorter hospital stays, faster recovery times, and reduced post-operative complications for patients.

The tumor ablation market is witnessing significant growth, driven by advancements in minimally invasive procedures such as radiofrequency ablation (RFA) and increasing adoption of liver ablation procedures. Radiofrequency ablation, a type of tumor ablation technique, utilizes heat generated by high-frequency alternating current to destroy cancerous cells. This innovative approach offers several advantages, including minimal invasiveness, reduced recovery time, and lower risk of complications compared to traditional surgical interventions. As a result, the demand for radiofrequency ablation procedures is on the rise, particularly for treating liver tumors and other solid tumors.

Market Segmentation

Market Research Future report offers a comprehensive segmental analysis of the tumor ablation market on the basis of technology, treatment, application and end-user.

Based on technology, it is segmented into cryoablation, irreversible electroporation, microwave, radiofrequency and others. Of these, radiofrequency will dominate the tumor ablation market during the forecast period. Prominent use of this technology to remove solid tumor and its specificity has resulted to its growth. Also, this method’s efficiency is expected to spur the segment growth. This will be followed by microwave ablation technology that is projected to have a remunerative growth due to the advantages provided by this technology namely optimal heating of cystic mass, reduced procedural pain, lesser time, constancy in high temperature and bigger tumor ablation volume.

Based on treatment, the tumor ablation market is segmented into laparoscopic, percutaneous and surgical. Of these, surgical will dominate the market during the forecast period owing to rising prevalence of breast and liver cancer that needs open surgical techniques. This will be followed by the percutaneous ablation that is projected to grow at the fastest pace.

Based on application, it is segmented into prostate cancer, bone cancer, breast cancer, lung cancer, liver cancer and others. Of these, liver cancer will have the largest share in the market owing to rising cases of both bile duct as well as primary liver cancers. Of these, lung cancer will lead the market during the forecast period owing to rising cases of the disease.

Based on end-user, the tumor ablation market is segmented into research institute, surgical and ablation centers and hospitals. Of these, hospitals will dominate the market due to increasing practices to visit the hospital for well-being along with the availability of various facilities in hospitals.

Key Players

Tumor ablation players include

Covidien PL,

Misonix Inc.,

Galil Medical, Inc,

Biotronik,

Boston Scientific Corporation,

Neuwave Medical, Inc.,

Healthtronics Inc.,

AngioDynamics Inc.,

EDAP TMS,

Medtronic Plc., and

SonaCare Medical.

Regional Analysis

By region, the tumor ablation market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain head and shoulders over other regions in the market. The growth can be attributed to factors such as increasing incidences of cancer amid rising elderly population, use of advanced healthcare facilities, favorable reimbursement policies, and increasing awareness regarding cancer detection as well as treatment. The tumor ablation market in Europe will grab the second position owing to rising prevalence of cancer coupled with increasing healthcare expenditure. The tumor ablation market in the APAC region will grow at the fastest pace due to high demand for advanced healthcare technologies, constantly growing investment in healthcare and rising geriatric population. On the other hand, the tumor ablation market in the Middle East and Africa will have a minimal share owing to poor medical facilities, dearth of technical knowledge and underdeveloped healthcare sector.

Related Reports-

RSV Diagnostics

Liver Biopsy

Biologic Therapy

US 3d medical printing

Epilepsy Diagnosis and Treatment

For more information, Please Visit us @ Market Research Future

Navigating the Landscape of Minimally Invasive Tumor Ablation Technologies: Market Trends and Forecasts

 Market Analysis

The global tumor ablation market size is projected to reach at a stellar 11.8% CAGR during the forecast period (2023-2032).

The Tumor Ablation Market refers to the segment of the medical device industry dedicated to developing and providing technologies and procedures for the ablation or destruction of tumors. Tumor ablation techniques are minimally invasive procedures that use various energy sources, such as radiofrequency, microwave, cryoablation, high-intensity focused ultrasound (HIFU), and laser, to target and eliminate cancerous tissue.

This market has experienced significant growth in recent years due to several factors. One of the primary drivers is the increasing incidence of cancer worldwide, coupled with a growing demand for less invasive treatment options. Tumor ablation procedures offer a less traumatic alternative to traditional surgery, resulting in shorter hospital stays, faster recovery times, and reduced post-operative complications for patients.

The tumor ablation market is witnessing significant growth, driven by advancements in minimally invasive procedures such as radiofrequency ablation (RFA) and increasing adoption of liver ablation procedures. Radiofrequency ablation, a type of tumor ablation technique, utilizes heat generated by high-frequency alternating current to destroy cancerous cells. This innovative approach offers several advantages, including minimal invasiveness, reduced recovery time, and lower risk of complications compared to traditional surgical interventions. As a result, the demand for radiofrequency ablation procedures is on the rise, particularly for treating liver tumors and other solid tumors.

Key Players

Tumor ablation market players include

Covidien PL,

Misonix Inc.,

Galil Medical, Inc,

Biotronik,

Boston Scientific Corporation,

Neuwave Medical, Inc.,

Healthtronics Inc.,

AngioDynamics Inc.,

EDAP TMS,

Medtronic Plc., and

SonaCare Medical.

Market Segmentation

Market Research Future report offers a comprehensive segmental analysis of the tumor ablation market on the basis of technology, treatment, application and end-user.

Based on technology, it is segmented into cryoablation, irreversible electroporation, microwave, radiofrequency and others. Of these, radiofrequency will dominate the tumor ablation market during the forecast period. Prominent use of this technology to remove solid tumor and its specificity has resulted to its growth. Also, this method’s efficiency is expected to spur the segment growth. This will be followed by microwave ablation technology that is projected to have a remunerative growth due to the advantages provided by this technology namely optimal heating of cystic mass, reduced procedural pain, lesser time, constancy in high temperature and bigger tumor ablation volume.

Based on treatment, the tumor ablation market is segmented into laparoscopic, percutaneous and surgical. Of these, surgical will dominate the market during the forecast period owing to rising prevalence of breast and liver cancer that needs open surgical techniques. This will be followed by the percutaneous ablation that is projected to grow at the fastest pace.

Based on application, it is segmented into prostate cancer, bone cancer, breast cancer, lung cancer, liver cancer and others. Of these, liver cancer will have the largest share in the market owing to rising cases of both bile duct as well as primary liver cancers. Of these, lung cancer will lead the market during the forecast period owing to rising cases of the disease.

Based on end-user, the tumor ablation market is segmented into research institute, surgical and ablation centers and hospitals. Of these, hospitals will dominate the market due to increasing practices to visit the hospital for well-being along with the availability of various facilities in hospitals.

Regional Analysis

By region, the tumor ablation market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain head and shoulders over other regions in the market. The growth can be attributed to factors such as increasing incidences of cancer amid rising elderly population, use of advanced healthcare facilities, favorable reimbursement policies, and increasing awareness regarding cancer detection as well as treatment. The tumor ablation market in Europe will grab the second position owing to rising prevalence of cancer coupled with increasing healthcare expenditure. The tumor ablation market in the APAC region will grow at the fastest pace due to high demand for advanced healthcare technologies, constantly growing investment in healthcare and rising geriatric population. On the other hand, the tumor ablation market in the Middle East and Africa will have a minimal share owing to poor medical facilities, dearth of technical knowledge and underdeveloped healthcare sector.

For more information, Please Visit us @ Market Research Future

Tumor Ablation Market Share Expected to reach a notable valuation by 2032

 

Market Analysis

The global tumor ablation market share is projected to reach at a stellar 11.8% CAGR during the forecast period (2023-2032). Tumor ablation is a technique that is minimally invasive and commonly used for treating tumors in the lung, bone, kidney and liver. During this process, thermal energy is utilized to cool or heat tissues to cytotoxic levels. Under its classification, there are various modalities used worldwide: irreversible electroporation, cryoablation, high-intensity focused ultrasound, laser, microwave and radiofrequency. Every technique though similar in purpose possess optimal and specific indications. Tumor ablation is a vital choice for those who have failed radiotherapy or chemotherapy or is not a candidate for surgery. It is also considered as the potential first-line treatment especially in patients with benign tumors in the liver or small hepatocellular carcinomas. This is a convenient and excellent treatment choice over the other conventional surgical methods.

There are several factors that is propelling the growth of the tumor ablation market. These factors according to MRFR (Market Research Future) report include rapid adoption of novel form of treatment for fighting cancer, growing public awareness programs for detecting cancer at the initial stage, funds offered by the government for cancer research, extensive use of minimally invasive methods due to its myriad benefits such as minimal complications, less trauma and speedy recovery, rising per capita income and various technological advancements such as HIFU (High-Intensity Focused Ultrasound), irreversible electroporation, laser ablation and thermal ablation. On the contrary, factors such as exorbitant price of tumor ablation methods, constraint subsidy scenarios, dearth of experts and strict regulations for product approval may restrain the growth of the tumor ablation market.

Key Players

Tumor ablation market players include Covidien PL, Misonix Inc., Galil Medical, Inc, Biotronik, Boston Scientific Corporation, Neuwave Medical, Inc., Healthtronics Inc., AngioDynamics Inc., EDAP TMS, Medtronic Plc., and SonaCare Medical.

Market Segmentation

Market Research Future report offers a comprehensive segmental analysis of the tumor ablation market outlook on the basis of technology, treatment, application and end-user.

Based on technology, it is segmented into cryoablation, irreversible electroporation, microwave, radiofrequency and others. Of these, radiofrequency will dominate the tumor ablation market during the forecast period. Prominent use of this technology to remove solid tumor and its specificity has resulted to its growth. Also, this method’s efficiency is expected to spur the segment growth. This will be followed by microwave ablation technology that is projected to have a remunerative growth due to the advantages provided by this technology namely optimal heating of cystic mass, reduced procedural pain, lesser time, constancy in high temperature and bigger tumor ablation volume.

Based on treatment, the tumor ablation market is segmented into laparoscopic, percutaneous and surgical. Of these, surgical will dominate the market during the forecast period owing to rising prevalence of breast and liver cancer that needs open surgical techniques. This will be followed by the percutaneous ablation that is projected to grow at the fastest pace.

Based on application, it is segmented into prostate cancer, bone cancer, breast cancer, lung cancer, liver cancer and others. Of these, liver cancer will have the largest share in the market owing to rising cases of both bile duct as well as primary liver cancers. Of these, lung cancer will lead the market during the forecast period owing to rising cases of the disease.

Based on end-user, the tumor ablation market is segmented into research institute, surgical and ablation centers and hospitals. Of these, hospitals will dominate the market due to increasing practices to visit the hospital for well-being along with the availability of various facilities in hospitals.

Regional Analysis

By region, the tumor ablation market insights growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain head and shoulders over other regions in the market. The growth can be attributed to factors such as increasing incidences of cancer amid rising elderly population, use of advanced healthcare facilities, favorable reimbursement policies, and increasing awareness regarding cancer detection as well as treatment. The tumor ablation market in Europe will grab the second position owing to rising prevalence of cancer coupled with increasing healthcare expenditure. The tumor ablation market in the APAC region will grow at the fastest pace due to high demand for advanced healthcare technologies, constantly growing investment in healthcare and rising geriatric population. On the other hand, the tumor ablation market in the Middle East and Africa will have a minimal share owing to poor medical facilities, dearth of technical knowledge and underdeveloped healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Tumor Ablation Market Players, Outlook, Trends, Size, Share, Scope, Regional Demand and Forecast To 2030

 

Market Analysis

The global tumor ablation market size is projected to reach USD 2.7 billion by 2030 anticipated to have an astronomical growth at a stellar 11.81% CAGR during the forecast period (2022-2030). Tumor ablation is a technique that is minimally invasive and commonly used for treating tumors in the lung, bone, kidney and liver. During this process, thermal energy is utilized to cool or heat tissues to cytotoxic levels. Under its classification, there are various modalities used worldwide: irreversible electroporation, cryoablation, high-intensity focused ultrasound, laser, microwave and radiofrequency. Every technique though similar in purpose possess optimal and specific indications. Tumor ablation is a vital choice for those who have failed radiotherapy or chemotherapy or is not a candidate for surgery. It is also considered as the potential first-line treatment especially in patients with benign tumors in the liver or small hepatocellular carcinomas. This is a convenient and excellent treatment choice over the other conventional surgical methods.

There are several factors that is propelling the growth of the tumor ablation market. These factors according to MRFR (Market Research Future) report include rapid adoption of novel form of treatment for fighting cancer, growing public awareness programs for detecting cancer at the initial stage, funds offered by the government for cancer research, extensive use of minimally invasive methods due to its myriad benefits such as minimal complications, less trauma and speedy recovery, rising per capita income and various technological advancements such as HIFU (High-Intensity Focused Ultrasound), irreversible electroporation, laser ablation and thermal ablation. On the contrary, factors such as exorbitant price of tumor ablation methods, constraint subsidy scenarios, dearth of experts and strict regulations for product approval may restrain the growth of the tumor ablation market.

Key Players

Tumor ablation market players include Covidien PL, Misonix Inc., Galil Medical, Inc, Biotronik, Boston Scientific Corporation, Neuwave Medical, Inc., Healthtronics Inc., AngioDynamics Inc., EDAP TMS, Medtronic Plc., and SonaCare Medical.

Market Segmentation

Market Research Future report offers a comprehensive segmental analysis of the tumor ablation market on the basis of technology, treatment, application and end-user.

Based on technology, it is segmented into cryoablation, irreversible electroporation, microwave, radiofrequency and others. Of these, radiofrequency will dominate the tumor ablation market during the forecast period. Prominent use of this technology to remove solid tumor and its specificity has resulted to its growth. Also, this method’s efficiency is expected to spur the segment growth. This will be followed by microwave ablation technology that is projected to have a remunerative growth due to the advantages provided by this technology namely optimal heating of cystic mass, reduced procedural pain, lesser time, constancy in high temperature and bigger tumor ablation volume.

Based on treatment, the tumor ablation market is segmented into laparoscopic, percutaneous and surgical. Of these, surgical will dominate the market during the forecast period owing to rising prevalence of breast and liver cancer that needs open surgical techniques. This will be followed by the percutaneous ablation that is projected to grow at the fastest pace.

Based on application, it is segmented into prostate cancer, bone cancer, breast cancer, lung cancer, liver cancer and others. Of these, liver cancer will have the largest share in the market owing to rising cases of both bile duct as well as primary liver cancers. Of these, lung cancer will lead the market during the forecast period owing to rising cases of the disease.

Based on end-user, the tumor ablation market is segmented into research institute, surgical and ablation centers and hospitals. Of these, hospitals will dominate the market due to increasing practices to visit the hospital for well-being along with the availability of various facilities in hospitals.

Regional Analysis

By region, the tumor ablation market insights growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain head and shoulders over other regions in the market. The growth can be attributed to factors such as increasing incidences of cancer amid rising elderly population, use of advanced healthcare facilities, favorable reimbursement policies, and increasing awareness regarding cancer detection as well as treatment. The tumor ablation market in Europe will grab the second position owing to rising prevalence of cancer coupled with increasing healthcare expenditure. The tumor ablation market in the APAC region will grow at the fastest pace due to high demand for advanced healthcare technologies, constantly growing investment in healthcare and rising geriatric population. On the other hand, the tumor ablation market in the Middle East and Africa will have a minimal share owing to poor medical facilities, dearth of technical knowledge and underdeveloped healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America